The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Current and Emerging Immunotherapeutic Strategies in Melanoma

Omid Hamid, MD
Published Online: 10:01 PM, Fri November 11, 2016

Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, discusses current and emerging immunotherapeutic strategies in the field of melanoma during an interview at the 34th Annual Chemotherapy Foundation SymposiumTM.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.